Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Natco Pharma CEO...

    Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

    Written by Ruby Khatun Khatun Published On 2017-06-24T11:27:44+05:30  |  Updated On 24 Jun 2017 11:27 AM IST
    Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

    Hyderabad: Mr Rajeev Nannapaneni, Vice Chairman and CEO, Natco Pharma Limited, donated 1.5 lakh shares valued at Rs 15 crores to Hyderabad Eye Research Foundation, the research arm of L V Prasad Eye Institute, to find innovative approaches to tackle the problems of blindness and visual impairment in children that can benefit India and other developing countries.


    Accepting this donation, Dr Gullapalli N Rao, Founder and Chair, L V Prasad Eye Institute (LVPEI) said, “It is exciting to see such spirit of generosity in youngsters like Rajeev and his wife, Swathi. This support will allow us to transform our efforts in children’s eye health and create a global resource centre with huge impact throughout the developing world. Millions of children will be treated by this act of generosity.”


    In 2016-17, children constituted 18% of LVPEI’s patient profile across locations.


    The Child Sight Institute is a children’s eye health division of LVPEI, encompassing all children’s eye health programmes that LVPEI are engaged in.


    This includes care at all levels from primary to advanced tertiary across four states – Telangana, Andhra Pradesh, Odisha and Karnataka. Every form of children’s eye problems can be treated at this Institute irrespective of the person’s ability to pay.


    In addition, this Institute will have partnerships with multiple centres in India and the developing countries. In education and research, it will build on existing collaborations with leading institutes in the US, Europe and Asia.

    CEOChild Sight InstituteDonationDr Gullapalli N RaoEye CareHyderabad Eye Research FoundationL V Prasad Eye InstituteMr Rajeev NannapaneniNatco pharma
    Source : PRESS RELEASE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok